Stem definition | Drug id | CAS RN |
---|---|---|
humanized origin | 4959 | 214745-43-4 |
Molecule | Description |
---|---|
Synonyms:
|
a humanized anti-CD11anti-adhesion monoclonal antibody
|
Dose | Unit | Route |
---|---|---|
10 | mg | P |
None
Date | Agency | Company | Orphan |
---|---|---|---|
Sept. 20, 2004 | EMA | ||
Oct. 27, 2003 | FDA | GENENTECH |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Psoriasis | 80.67 | 75.13 | 26 | 306 | 86931 | 63401759 |
None
None
None
Source | Code | Description |
---|---|---|
ATC | L04AA21 | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS IMMUNOSUPPRESSANTS IMMUNOSUPPRESSANTS Selective immunosuppressants |
FDA CS | M0001357 | Antibodies, Monoclonal |
FDA MoA | N0000175856 | CD11a-directed Antibody Interactions |
FDA EPC | N0000175858 | CD11a-directed Humanized IgG1 Antibody |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Plaque psoriasis | indication | 200965009 |
None
None
None
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Leukocyte adhesion glycoprotein LFA-1 alpha | Adhesion | ANTIBODY BINDING | Kd | 11.40 | IUPHAR | DRUG LABEL |
ID | Source |
---|---|
D03959 | KEGG_DRUG |
4021411 | VUID |
N0000148826 | NUI |
4021411 | VANDF |
CHEMBL1201575 | ChEMBL_ID |
C472181 | MESH_SUPPLEMENTAL_RECORD_UI |
6593 | IUPHAR_LIGAND_ID |
DB00095 | DRUGBANK_ID |
356988 | RXNORM |
17649 | MMSL |
47678 | MMSL |
d04902 | MMSL |
005208 | NDDF |
407005009 | SNOMEDCT_US |
407006005 | SNOMEDCT_US |
C1174995 | UMLSCUI |
8122 | INN_ID |
XX2MN88N5D | UNII |
None